Susceptibility of hypertensive rats to a new hypotensive agent, ST-155 (catapres): 2-(2,6-dichorophenylamino)-2-imidazoline hydrochloride.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D003000:Clonidine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D010208:Papaverine / Q000494:pharmacology; D010946:Plants, Medicinal; D010947:Plants, Toxic; D051381:Rats; D011919:Rats, Inbred Strains; D014630:Vagus Nerve / Q000187:drug effects; D014703:Veratrum / Q000494:pharmacology
D000959:Antihypertensive Agents; D006584:Hexamethonium Compounds; D007093:Imidazoles; D001285:Atropine; D010208:Papaverine; D007545:Isoproterenol; D003000:Clonidine